文献速递类风湿关节炎

在早期类风湿关节炎中,合并症不能解释肥胖患者未达到缓解风险增加

In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesity.
PubMed 文献 · RMD Open · 2025-04-15

基于瑞典EIRA研究2006-2018年1285例起始甲氨蝶呤单药治疗的早期类风湿关节炎患者,分析肥胖与超重是否独立关联缓解失败。6个月时肥胖组64%(98/153)、超重组52%(171/326)、正常体重组48%(210/433)未达DAS28缓解;校正年龄性别后肥胖组RR=1.33(95%CI 1.14至1.55),进一步校正合并症等后RR=1.27(95%CI 1.08至1.50),超重无显著关联。结论认为肥胖是早期RA缓解失败的独立危险因素。

要点

  • 6个月时未达DAS28缓解比例:肥胖组64%(98/153)、超重组52%(171/326)、正常体重组48%(210/433)。
  • 校正年龄性别后肥胖组缓解失败RR=1.33(95%CI 1.14至1.55),进一步校正合并症等后RR=1.27(95%CI 1.08至1.50)。
  • 超重组未观察到显著关联,次要结局及3个月结果与主要结果相似。

核心结论

  • 肥胖是早期类风湿关节炎缓解失败的独立危险因素,不受合并症影响。

研究设计与样本

  • 基于EIRA研究2006-2018年纳入的1285例起始甲氨蝶呤单药治疗的早期类风湿关节炎患者,链接瑞典全国临床与质量登记数据,采用改良Poisson回归估计相对风险。

主要发现

  • 6个月时肥胖组64%(98/153)、超重组52%(171/326)、正常体重组48%(210/433)未达到DAS28缓解。
  • 校正年龄和性别后,肥胖组缓解失败RR=1.33(95%CI 1.14至1.55)。
  • 进一步校正血清阳性、教育水平、吸烟、饮酒、体力活动、日历时期、糖皮质激素治疗及合并症后,肥胖组RR=1.27(95%CI 1.08至1.50)。
  • 超重组未观察到显著关联,次要结局及3个月结果与主要结果相似。

关键数值与推荐

  • 主要结局为3个月和6个月未达到DAS28缓解。
  • 次要结局包括Boolean缓解、简化疾病活动指数(SDAI)和临床疾病活动指数(CDAI)缓解及其各组分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine whether obesity and/or overweight are independently associated with an increased risk of remission failure in patients with early rheumatoid arthritis (RA), treated with methotrexate as first disease-modifying antirheumatic drug, or if the previously reported associations could be explained by underlying comorbidities and lifestyle factors. METHODS: For patients included in the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study 2006-2018 initiating methotrexate monotherapy (n=1285), we captured data on body mass index, comorbidities and disease activity from EIRA and through linkage to nationwide Swedish clinical and quality registers. The primary outcome was failure to reach 28-joint Disease Activity Score (DAS28) remission at 3 and 6 months. Secondary outcomes included Boolean, Simplified Disease Activity Index and Clinical Disease Activity Index remission and their individual components. We estimated the relative risk (RR) of remission failure in patients with obesity and overweight compared with normal weight using modified Poisson regression, adjusting for potential confounders. RESULTS: After 6 months, 64% (n=98/153) of patients with obesity, 52% (n=171/326) with overweight and 48% (n=210/433) with normal weight failed to reach DAS28 remission, with an RR of 1.33 (95% CI 1.14 to 1.55) for patients with obesity after adjustment for age and sex. The increased risk of remission failure in patients with obesity remained after further adjustment for seropositivity, educational level, smoking, alcohol use, physical activity, calendar period, glucocorticoid treatment and comorbidities (RR=1.27, 95% CI 1.08 to 1.50). No significant association was observed for patients with overweight. The results were similar for the secondary outcomes and after 3 months. CONCLUSION: Obesity is a risk factor for remission failure in early RA, independent of comorbid conditions.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Tidblad L, Öberg Sysojev A, Delcoigne B, et al. In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesity. RMD Open. 2025. PMID: 40234098. doi:10.1136/rmdopen-2025-005430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。